MedPath

通化万通药业股份有限公司

Ownership
-
Established
2001-01-22
Employees
-
Market Cap
-
Website
www.wtyy.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

128

NMPA:128

Drug Approvals

Repaglinide Tablets

Product Name
瑞格列奈片
Approval Number
国药准字H20253152
Approval Date
Jan 14, 2025
NMPA

Esomeprazole Magnesium Enteric-coated Capsules

Product Name
艾司奥美拉唑镁肠溶胶囊
Approval Number
国药准字H20244704
Approval Date
Aug 20, 2024
NMPA

Esomeprazole Magnesium Enteric-coated Capsules

Product Name
艾司奥美拉唑镁肠溶胶囊
Approval Number
国药准字H20244703
Approval Date
Aug 20, 2024
NMPA

Bifonazole Cream

Product Name
联苯苄唑乳膏
Approval Number
国药准字H20057704
Approval Date
Jun 27, 2024
NMPA

Dapoxetine Hydrochloride Tablets

Product Name
盐酸达泊西汀片
Approval Number
国药准字H20243544
Approval Date
Apr 17, 2024
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20243441
Approval Date
Apr 7, 2024
NMPA

景志安神片

Approval Number
国药准字Z20090599
Approval Date
Sep 27, 2023
NMPA

景志安神胶囊

Approval Number
国药准字Z20090389
Approval Date
Sep 27, 2023
NMPA

精制冠心片

Approval Number
国药准字Z20093097
Approval Date
Sep 27, 2023
NMPA

调经养颜片

Approval Number
国药准字Z20090166
Approval Date
Sep 21, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.